Home
About
Overview
Sharing Data
ORCID
Help
History (38)
Modular folding and evidence for phosphorylation-induced stabilization of an hsp90-dependent kinase.
Chromosomes, Human, 16-18
Crystal structure of the middle and C-terminal domains of Hsp90a labeled with a coumarin derivative reveals a potential allosteric binding site as a drug target.
Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Abelacimab for Prevention of Venous Thromboembolism.
See All 38 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Abelacimab for Prevention of Venous Thromboembolism.
Abelacimab for Prevention of Venous Thromboembolism. N Engl J Med. 2021 08 12; 385(7):609-617.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Anticoagulants
Arthroplasty, Replacement, Knee
Dose-Response Relationship, Drug
Enoxaparin
Factor XI
Female
Hemorrhage
Humans
Infusions, Intravenous
Injections, Subcutaneous
Male
Middle Aged
Partial Thromboplastin Time
Postoperative Complications
Venous Thromboembolism
authors with profiles
Gary E Raskob